MyAverix Finance
HK · Healthcare
China Pioneer Pharma Holdings Ltd (1345)
Pharmaceutical Retailers
China Pioneer Pharma Holdings Ltd (1345) is listed on HK in the Healthcare sector. Industry: Pharmaceutical Retailers. As of 2026-05-21, reported market cap is $2.58B, P/E ratio is 18.58, net margin is 8.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 1345
China Pioneer Pharma Holdings Ltd (1345) — FAQ
What is China Pioneer Pharma Holdings Ltd's market cap?
China Pioneer Pharma Holdings Ltd (1345) has a reported market cap of $2.58B (data as of 2026-05-21).
What is 1345's P/E ratio?
The price-to-earnings (P/E) ratio for China Pioneer Pharma Holdings Ltd (1345) is 18.58 (data as of 2026-05-21).
Does China Pioneer Pharma Holdings Ltd pay a dividend?
Dividend yield is not available in the current snapshot for China Pioneer Pharma Holdings Ltd (1345). Check the MyAverix Finance app for the latest dividend data.
What sector is China Pioneer Pharma Holdings Ltd in?
China Pioneer Pharma Holdings Ltd (1345) is classified in the Healthcare sector (Pharmaceutical Retailers industry).
What exchange is 1345 listed on?
1345 is listed on HK.
What is China Pioneer Pharma Holdings Ltd's net margin?
China Pioneer Pharma Holdings Ltd (1345) reports a net margin of 8.9% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.